5911 - 5920 of 7915 Results
Title
Year
-
OPENTitle: Establishing the role of rare coding variants in known Parkinson's disease risk lociJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 59Issue #:Start Page: 220.e11End Page: 220.e18Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.07.009Best OA location URL: https://orca.cardiff.ac.uk/id/eprint/109440/1/Establishing%20the%20role%20of%20rare%20coding%20variants%20in%20known%20Parkinson.pdfCitation Count: 17
-
RESTRICTEDTitle: Microglial phenotypes in Parkinson’s disease and animal models of the diseaseJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 155Issue #:Start Page: 57End Page: 75Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2016.04.006Best OA location URL: https://europepmc.org/articles/pmc5073045?pdf=renderCitation Count: 207
-
OPENTitle: mzStudio: A Dynamic Digital Canvas for User-Driven Interrogation of Mass Spectrometry DataJournal Name: ProteomesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/proteomes5030020Best OA location URL: https://www.mdpi.com/2227-7382/5/3/20/pdf?version=1501590909Citation Count: 22
-
RESTRICTEDTitle: The role of neurotransmitters in the development of Parkinson's disease‐related psychosisJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 10Start Page: 1244End Page: 1254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.13376Citation Count: 48
- Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia2017OPENTitle: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-017-0276-4Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-017-0276-4Citation Count: 110
- Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis2017OPENTitle: Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling AnalysisJournal Name: Clinical and Translational SciencePublisher: WileyVol: 11Issue #: 1Start Page: 63End Page: 70Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cts.12492Best OA location URL: https://doi.org/10.1111/cts.12492Citation Count: 40
- Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 response2017OPENTitle: Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 responseJournal Name: Journal of Leukocyte BiologyPublisher: Oxford University Press (OUP)Vol: 102Issue #: 4Start Page: 1093End Page: 1102Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1189/jlb.1a0417-147rrBest OA location URL: https://jlb.onlinelibrary.wiley.com/doi/pdfdirect/10.1189/jlb.1A0417-147RRCitation Count: 29
-
RESTRICTEDTitle: No evidence for toxicity after long-term photobiomodulation in normal non-human primatesJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 235Issue #: 10Start Page: 3081End Page: 3092Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-017-5048-7Citation Count: 33
- Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study2017OPENTitle: Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental StudyJournal Name: Health Services ResearchPublisher: WileyVol: 53Issue #: S1Start Page: 2735End Page: 2757Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/1475-6773.12744Best OA location URL: https://europepmc.org/articles/pmc6056595?pdf=renderCitation Count: 23
- A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations2017RESTRICTEDTitle: A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerationsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 8Start Page: 1117End Page: 1130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27090Best OA location URL: https://europepmc.org/articles/pmc5638072?pdf=renderCitation Count: 55